Data / Form D filings / KALA BIO, Inc.
KALA BIO, Inc.: Form D filings
KALA BIO, Inc., a pharmaceuticals company in Arlington, MA, filed 12 Form D notices with the SEC between 2009 and 2026. The latest, on March 17, 2026, reports $1.8 million sold of a $1.8 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1167 MASSACHUSETTS AVENUE, Arlington, MA, 02476
- Phone
- (781) 996-5252
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1479419
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | New notice | $1,753,500 | $1,753,500 | 1 | Mar 3, 2026 | sec.gov | |
| Feb 13, 2026 | New notice | $4,200,000 | $2,250,600 | $1,949,400 | 20 | Jan 30, 2026 | sec.gov |
| Dec 31, 2024 | New notice | $10,749,667 | $10,749,667 | 6 | Dec 31, 2024 | sec.gov | |
| Jun 28, 2024 | New notice | $12,499,192 | $12,499,192 | 5 | Jun 28, 2024 | sec.gov | |
| Nov 29, 2021 | New notice | $36,522,541 | $16,122,541 | $20,400,000 | 26 | Nov 15, 2021 | sec.gov |
| Apr 13, 2016 | New notice | $67,921,796 | $67,921,796 | 25 | Apr 6, 2016 | sec.gov | |
| Aug 19, 2015 | New notice | $6,999,999 | $6,999,999 | 1 | Aug 17, 2015 | sec.gov | |
| Apr 24, 2014 | New notice | $22,500,000 | $22,500,000 | 16 | Apr 16, 2014 | sec.gov | |
| Feb 28, 2013 | New notice | $11,500,118 | $5,750,059 | $5,750,059 | 10 | Feb 14, 2013 | sec.gov |
| Mar 14, 2012 | New notice | $7,243,205 | $7,243,205 | 10 | Feb 29, 2012 | sec.gov | |
| Nov 10, 2010 | New notice | $3,000,000 | $3,000,000 | 9 | Oct 26, 2010 | sec.gov | |
| Dec 23, 2009 | New notice | $2,000,001 | $2,000,001 | 10 | Dec 11, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Avi Minkowitz | Executive Officer, Director | |
| Hillel Posen | Director | |
| Chaim Berger | Director | |
| Yonatan Colman | Director | |
| Brendan Purdy | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what KALA BIO, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.